04/01/2024 6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/27/2024 4:53 PM | Del Giudice Matthew Paul (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:53 PM | MacPherson Edward Clouston (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:53 PM | Jerman Michael Allen (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:53 PM | MIRA Pharmaceuticals (Issuer) Yanez Michelle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:53 PM | MIRA Pharmaceuticals (Issuer) Shekhat Denil Nanji (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 4:53 PM | Aminov Erez (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/22/2024 6:00 PM | MIRA Pharmaceuticals (Issuer) Shekhat Denil Nanji (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/13/2024 3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2024 3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/17/2024 3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
12/27/2023 4:27 PM | Bay Shore Trust (Filed by) MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/27/2023 4:33 PM | Bay Shore Trust (Reporting) McNulty Brian Patrick (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:50 PM | MIRA Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/01/2023 4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2023 3:15 PM | Jerman Michael Allen (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2023 3:18 PM | Bay Shore Trust (Filed by) MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/20/2023 7:10 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:31 PM | Daly Brian Frederick (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/25/2023 3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 3:23 PM | Bay Shore Trust (Filed by) MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/12/2023 3:26 PM | McNulty Brian Patrick (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/18/2023 4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 424B3 | |
09/15/2023 3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/31/2023 4:27 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2023 4:38 PM | Bay Shore Trust (Reporting) Cappy George (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 5:00 PM | Aminov Erez (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 5:00 PM | Chapman Christopher C JR (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 5:00 PM | MIRA Pharmaceuticals (Issuer) Yanez Michelle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 5:00 PM | MIRA Pharmaceuticals (Issuer) Nicholoudis Christos (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 4:25 PM | Bay Shore Trust (Filed by) MIRA Pharmaceuticals (Subject)
| Form SC 13D | |
08/04/2023 12:42 PM | Bay Shore Trust (Reporting) Cappy George (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2023 11:59 AM | MIRA Pharmaceuticals (Filer)
| Form 424B1 | |
08/04/2023 12:01 PM | MIRA Pharmaceuticals (Filer)
| Form 424B4 | |
08/02/2023 11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
08/02/2023 4:58 PM | Kroenig Bradley (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 5:00 PM | McColl Hugh III (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 5:03 PM | MIRA Pharmaceuticals (Issuer) Nicholoudis Christos (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 5:05 PM | MIRA Pharmaceuticals (Issuer) Tuck Talhia (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 5:08 PM | MIRA Pharmaceuticals (Issuer) Vorhoff David C (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Elon’s New Device is About to Shock the World (Ad) Using this device you see above…
Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in…
“The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. |
08/02/2023 5:10 PM | MIRA Pharmaceuticals (Issuer) Yanez Michelle (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 5:13 PM | Bay Shore Trust (Reporting) Cappy George (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 4:49 PM | Aminov Erez (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 4:52 PM | Chapman Christopher C JR (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 4:55 PM | Kaplin Adam (Reporting) MIRA Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/31/2023 4:24 PM | MIRA Pharmaceuticals (Filer)
| Form CERT | |
07/31/2023 2:54 PM | MIRA Pharmaceuticals (Filer)
| Form 8-A12B | |
07/28/2023 2:14 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/21/2023 4:20 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/18/2023 4:14 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/14/2023 4:08 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
06/29/2023 3:39 PM | MIRA Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |